Trialjectory

Series-A
trialjectory.com AI & Machine Learning New York, United States
Total Funding $20M
Latest Round $20M Series-A
Last Announced Feb 7, 2022
Investors Undisclosed
Decision Makers 4 Available

About Trialjectory

TrialJectory develops an AI-powered platform that matches cancer patients to personalized treatments and clinical trials.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Series-A
Global Headquarters New York, United States
Tracked Since Nov 17, 2026

Web & Domain Identity

Official Website trialjectory.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $20,000,000 · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Trialjectory.

Funding History

1 Round
Series-A equity · Feb 7, 2022

Press Coverage & Sources

More AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts